Advertisement
Research ArticleBrain
Open Access

Brain Iron Quantification in Mild Traumatic Brain Injury: A Magnetic Field Correlation Study

E. Raz, J.H. Jensen, Y. Ge, J.S. Babb, L. Miles, J. Reaume, R.I. Grossman and M. Inglese
American Journal of Neuroradiology November 2011, 32 (10) 1851-1856; DOI: https://doi.org/10.3174/ajnr.A2637

Abstract

BACKGROUND AND PURPOSE: Experimental studies have suggested a role for iron accumulation in the pathology of TBI. Magnetic field correlation MR imaging is sensitive to the presence of non-heme iron. The aims of this study are to 1) assess the presence, if any, and the extent of iron deposition in the deep gray matter and regional white matter of patients with mTBI by using MFC MR imaging; and 2) investigate the association of regional brain iron deposition with cognitive and behavioral performance of patients with mTBI.

MATERIALS AND METHODS: We prospectively enrolled 28 patients with mTBI. Eighteen healthy subjects served as controls. The subjects were administered the Stroop color word test, the Verbal Fluency Task, and the Post-Concussion Symptoms Scale. The MR imaging protocol (on a 3T imager) consisted of conventional brain imaging and MFC sequences. After the calculation of parametric maps, MFC was measured by using a region of interest approach. MFC values across groups were compared by using analysis of covariance, and the relationship of MFC values and neuropsychological tests were evaluated by using Spearman correlations.

RESULTS: Compared with controls, patients with mTBI demonstrated significant higher MFC values in the globus pallidus (P = .002) and in the thalamus (P = .036). In patients with mTBI, Stroop test scores were associated with the MFC value in frontal white matter (r = −0.38, P = .043).

CONCLUSIONS: MFC values were significantly elevated in the thalamus and globus pallidus of patients with mTBI, suggesting increased accumulation of iron. This supports the hypothesis that deep gray matter is a site of injury in mTBI and suggests a possible role for iron accumulation in the pathophysiological events after mTBI.

Abbreviations

DAI
diffuse axonal injury
EPI
echo-planar imaging
FSE
fast spin-echo
GCS
Glasgow Coma Scale
GE
gradient-echo
MFC
magnetic field correlation
MFI
microscopic field inhomogeneity
MPRAGE
magnetization-prepared rapid acquisition of gradient echo
mTBI
mild traumatic brain injury
PCS
postconcussive syndrome
PCSS
Post-Concussion Symptoms Scale
ROI
region of interest
TBI
traumatic brain injury
VFT
Verbal Fluency Test

mTBI accounts for 90% of the new cases of head trauma diagnosed annually in the United States,1 with an annual incidence rate as high as 128/100,0002,3 and an estimated total lifetime annual cost of US$17 billion.4 Up to 15% of patients with mTBI will suffer a PCS3 characterized by persistent disabling physical (headache, dizziness), cognitive (memory loss, attention deficit), and emotional/behavioral (depression, anxiety) symptoms. Although the injury associated with moderate and severe trauma is usually evident on conventional MR imaging as hemorrhagic lesions or contusions, in most cases of mTBI both CT and MR imaging scans do not show obvious lesions.5 Likewise, although DAI is a common finding in moderate and severe TBI, in case of mTBI, not only there is a paucity of classic DAI-related MR findings but also the few injuries detected are focal and cannot justify the stereotypical global PCS symptoms.

This has been attributed to the inability of routine imaging to reveal the presence of microscopic brain damage that has been reported by studies in experimental models and autoptic tissue of patients with mTBI.6 Animal studies also have shown that mild head injury can cause oxidative stress injury and subtle axonal damage in the absence of gross focal lesions.7,8 In addition, trauma-induced increased blood-brain barrier permeability9 and hemoglobin degradation products can be detected in the absence of focal lesions,10 suggesting a mechanism for excessive iron deposition in TBI. A role for iron accumulation in the pathology of TBI has been suggested by a recent correlative MR imaging-histologic study11 that examined the brains of mice after a controlled cortical impact injury. Interestingly, a T2 hypointensity, which showed increased staining of iron at the histologic examination, was observed in the thalamus ipsilateral to the acute cortical impact injury. In the postacute period, astrogliosis and microgliosis were observed in the ipsilateral thalamus, raising the possibility that iron accumulation may trigger the pathologic events after TBI.11

MFC is a recently introduced MR imaging metric12–14 that has a direct relationship to the MFIs created by spatial variations in magnetic susceptibility, such as those generated by macroscopic structures (air, cavities, large veins, or bone) and iron-rich cells, with length scales ranging roughly from 1 to 100 μm. MFC MR imaging has been applied to the study of a patient with aceruloplasminemia,12 showing increased values in the globus pallidus, thalamus, and frontal white matter, consistent with the increased brain iron concentration, typical of this neurologic disease. An MFC MR imaging study of patients with multiple sclerosis also has demonstrated increased MFC index in the deep gray matter,15 plausibly reflecting iron deposition secondary to the presence and number of white matter lesions typical of the disease. The aims of our study were to 1) assess the presence, if any, and the extent of iron deposition in the gray matter and regional white matter of patients with mTBI by using MFC as an iron biomarker; and 2) investigate the association of regional brain iron deposition with cognitive and behavioral performance of patients with mTBI.

Materials and Methods

Patients

The study population was a series of patients with a well-documented clinical history of mTBI recruited prospectively from our hospital records and emergency department. All patients experienced a closed head injury resulting in an alteration of mental status. Inclusion criteria were 1) diagnosis of mTBI and 2) age between 18 and 60 years. mTBI was defined according to established criteria16: 1) posttraumatic amnesia not >24 hours, 2) GCS score between 13 and 15, and 3) loss of consciousness of approximately ≤30 minutes. Exclusion criteria were 1) a history of other neurologic disease, 2) psychiatric disturbance, 3) a history of substance or alcohol abuse, and 4) contraindications to performing MR imaging. Accordingly, 2 patients were excluded due to history of alcohol abuse, and 2 patients had contraindications to performing MR imaging. The remaining 28 patients were included in the study. A board-certified neurologist clinically evaluated all patients, and a clinical psychologist performed the neuropsychologic tests. The 28 patients had a mean age of 35.6 ± 10.4 years; there were 9 women and 19 men. The mean time interval between the trauma and the MR imaging examination was 559 ± 803 days. The GCS score was 13 in 4 patients, 14 in 9 patients, and 15 in 15 patients. Eighteen healthy volunteers (7 women and 11 men; mean age, 34.6 ± 7.4 years) were enrolled as controls. The study was approved by the institutional review board of our university, and it was in compliance with the Health Insurance Portability and Accountability Act. Written informed consent was obtained from all the participants.

Neuropsychological Tests

All subject were administered the Stroop test17 and the Delis-Kaplan Executive Function System VFT,18 but only the patients were administered the PCSS19; all tests were administered within 24 hours of undergoing the MR imaging scan. The Stroop test is a test of executive function that assesses the ability to inhibit habituated responses. The VFT is also a test of executive function, assessing verbal fluency, speed of information processing, and mental flexibility. For ease of comparison, scores for the Stroop and VFT were transformed into z scores. Patients who were at or below the fifth percentile (−1.6 SDs below the normative mean) of performance on each test compared with controls were categorized as cognitively impaired. The PCSS is a self-report questionnaire that assesses the severity of 19 symptoms associated with PCS/mild cognitive impairment. Items are rated on a Likert scale, indicating severity of the symptom, from 0 (none) to 6 (severe).

MR Imaging Acquisition

All subjects underwent MR imaging on a 3T scanner (Tim Trio; Siemens Medical Solutions, Erlangen, Germany). The body coil was used for signal intensity transmission, and the manufacturer-provided 12-channel head coil designed for parallel imaging was used for signal intensity reception. Section orientation parallel to the subcallosal line was assured by acquiring a multiplanar T1-weighted localizer at the beginning of each study. The MR imaging protocol included the following sequences:

  1. Axial T2-weighted FSE sequence on 22 sections (TR = 5700 ms, TE = 113 ms, matrix = 487 × 635, FOV = 320 × 320 mm2, section thickness = 3 mm, intersection gap = 3 mm, acceleration factor = 2, scanning time = 3 minutes 15 seconds.

  2. Sagittal 3D T1 MPRAGE sequence on 160 contiguous sections (TR = 2300 ms, TE = 3 ms, TI = 900 ms, flip angle = 9°, matrix = 487 × 635, FOV = 240 × 240 mm2, section thickness = 1 mm, intersection gap = 0 mm, acceleration factor = 2, scanning time = 4 minutes 21 seconds).

  3. Axial T2 GE sequence on 22 sections (TR = 800 ms, TE = 20 ms, flip angle = 15°, matrix = 487 × 635, FOV = 320 × 320 mm2, section thickness = 3 mm, intersection gap = 2 mm, acceleration factor = 2, scanning time = 3 minutes 35 seconds).

  4. Axial MFC by using a segmented (4 shot) EPI asymmetric echo sequence on 48 sections (TR = 5130 ms, TE = 40 ms, matrix = 128 × 128, flip angle = 90°, FOV = 256 × 256 mm2, bandwidth = 1346 Hz/pixel, section thickness = 1.7 mm, intersection gap = 0 mm [resulting in isotropic voxels], scanning time = 6 minutes 8 seconds). Images were acquired with refocusing pulse time shifts of ts = 0, −4, and −16 ms, where the negative sign indicates a reduction of the interval between the initial 90° excitation pulse and 180° refocusing pulse from the usual spin-echo value of TE/2. For each set of imaging parameters, 4 images were acquired to increase the signal intensity–to-noise ratio.12

Postprocessing

The MR images were transferred off-line and processed by an MR expert and a neuroradiologist; T2-FSE, T1-MPRAGE, and T2-GE were reviewed for any area of altered signal intensity. The postprocessing of MFC was performed in Matlab 7.0 (MathWorks, Natick, Massachusetts), by using the SPM 5 software (Wellcome Department of Cognitive Neurology, London, England) as described in detail previously.12,13 For a biologic tissue in an applied magnetic field, the MFC may be defined by the following equation: Embedded Image with δB(t) being the magnitude difference between the total and background fields for a water molecule at a time t and with γ being the proton gyromagnetic ratio.12,13 In the equation, the field product within brackets is averaged over all water molecules within a voxel. Because of time translation invariance, the MFC depends only on the time difference. Thus, the MFC provides a quantitative means of characterizing MFIs. After coregistration and smoothing, the 4 repetitions were averaged for each refocusing shift and the parametric maps of the MFC were generated, determined from a least-squares nonlinear equation by using in-house Matlab scripts.12,13 Using ImageJ (http://rsbweb.nih.gov/ij/index.html), standard ellipse-shaped ROIs of the following brain regions were then outlined on T2 images and applied on 3 consecutive coregistered MFC maps: the caudate nucleus, thalamus, putamen, globus pallidus, the frontal white matter bilaterally and the splenium of the corpus callosum. The standard ellipse-shaped ROIs (Fig 1) were placed by a neuroradiologist (E.R.) who adjusted the size and orientation depending on the brain area analyzed (eg, globus pallidus, thalamus, caudate nucleus) on 3 contiguous sections bilaterally. The mean MFC value (unit of measure = s−2) and SD of the ROIs were calculated and then averaged over sections and brain side.

Fig 1.
Fig 1.

Representative of the ROIs drawn on 2 sample T2 images at the level of basal ganglia and centrum semiovale.

Statistical Analysis

Mixed model analysis of covariance was used to compare subject groups in terms of regional MFC values adjusted for age and sex. Specifically, the regional MFC measures were modeled as functions of subject group, age, and sex. The correlation structure imparted by the inclusion of multiple MFC values per subject was modeled by assuming data to be correlated only when acquired from the same subject and by allowing the error variance to differ across comparison groups (to eliminate the assumption of variance homogeneity). Spearman rank correlations were used to assess the relationship of MFC values with the Stroop and VFT z scores, the PCSS scores, and the elapsed time from injury. Because Stroop, VFT, PCSS, and elapsed time from injury are subject-level factors, each was correlated with MFC values represented for each subject as an average. All reported P values are 2-sided, and statistical significance is defined as P <.05. SAS 9.0 (SAS Institute, Cary, North Carolina) was used for all computations.

Results

All patients with mTBI suffered blunt head trauma (eg, motor vehicle crash, bicycle accident, fall, assault). Most of the patients experienced residual symptoms as detailed in Table 1. T2-FSE and T1-MPRAGE images showed no area of altered signal intensity either in patients or in healthy volunteers. T2-GE showed a dotlike hypointensity in the fusiform gyrus of 1 patient. Mean and SDs of MFC values in patients with mTBI and controls are reported in Table 2. Compared with healthy volunteers, patients demonstrated significantly higher MFC values in the globus pallidus (P = .002) and the thalamus (P = .036). Representative MFC maps with corresponding T2 images from 2 brain sections of 2 patients with mTBI (Figs 2 and 3) and a healthy subject (Fig 4) are shown.

Fig 2.
Fig 2.

Representative MFC color maps and correspondent T2 images of 2 brain sections at the level of globus pallidus and thalamus in a 42-year-old male patient with mTBI. The patient complained of neck stiffness; his GCS score was 15, and the conventional MR imaging scan was normal. Note the clearly increased MFC in the deep gray matter and the correspondent normal T2 images. MFC values are reported in s−2.

Fig 3.
Fig 3.

Representative MFC color maps and correspondent T2 images of 2 brain sections at the level of globus pallidus and thalamus in a 25-year-old male patient with mTBI. The patient complained of headache, neck stiffness, photophobia, and nausea; his GCS score was 13, and the conventional MR imaging scan was normal. Note the clearly increased MFC in the deep gray matter and the correspondent normal T2 images. MFC values are reported in s−2.

Fig 4.
Fig 4.

Representative MFC color maps and correspondent T2 images of 2 brain sections at the level of globus pallidus and thalamus in a 32-year-old male healthy volunteer. MFC values are reported in s−2.

View this table:
Table 1:

Clinical symptoms in the patient group

View this table:
Table 2:

Average MFC values (s−2) ± SDs in healthy controls and patients with mild traumatic brain injury

The mean PCSS score of patients with mTBI was 34 ± 25. The mean Stroop color word test and the VFT test z scores were significantly lower (P = .018 and P = .012, respectively) in patients with mTBI (−0.82 ± 1.82 and −0.28 ± 1.35, respectively) than in healthy controls (0.43 ± 0.42 and 0.93 ± 1.23, respectively). Seven of 28 patients (25%) were deemed impaired on the Stroop test, and 7 of 28 patients (25%) on the VFT test score. In patients with mTBI, the Stroop test scores were inversely associated with the MFC value in frontal white matter (r = −0.38, P = .043). PCSS and VFT tests did not show significant association with the MFC value of any of the examined brain regions (P >.07). In controls, there were no significant correlations between MFC values and Stroop or VFT test scores (P > .16).

Finally, no correlations were found between the MFC value of any of the examined regions and the interval from trauma (P > .13).

Discussion

Using a newly developed MFC method, we have observed increased MFC values in the deep gray matter of patients with mTBI, suggesting a role for iron in the pathophysiologic cascade of events after the traumatic insult. In addition, our findings support the hypothesis that not only white matter regions and the gray-white matter junction are injured by the shear stress forces associated to the traumatic event but also subcortical gray matter regions such as the thalamus and the globus pallidus.

We used for our study the MFC sequence: although the conventional method for exploiting the effect of MFIs has been to measure the relaxation rates R2, R2*, and R2′, this has possible disadvantages; in particular R2 and R2* are influenced by other relaxation mechanisms such as dipolar interactions, whereas MFC depends only on MFIs and weakly on water diffusion. Although R2′ can provide a better characterization of MFIs than R2 and R2*, the precise physical meaning of R′ is not well determined, and it is more dependent on the experimental technique.14 In contrast, MFC has a more direct relationship to the MFIs, allowing for a clearer physical interpretation.12

Although less susceptible to direct damage, the deep gray matter nuclei are more sensitive to shear and strain damage because of the long fibers that originate or pass through them.3,20,21 The thalami and basal ganglia are the centrally located relay station for information throughout the brain, and they participate in communication among sensory, motor and associative areas;22 thus, damage to these structures can determine widespread functional impairments.23

The mechanism of the excessive accumulation of iron in deep gray matter in mTBI is not well known, and it is probably multifactorial. Iron is essential for many metabolic functions including the biosynthesis of neurotransmitters and formation of myelin.24 Abnormal iron deposition, however, can be injurious to the central nervous system25 by inducing oxidative stress that facilitates neuronal death and neurodegeneration.26 Whether accumulation of iron is the primary pathologic factor of the traumatic insult or a secondary effect due to diffuse axonal injury of white matter regions is uncertain; however, its toxic effects on lipids, carbohydrates, proteins, and nucleic acids are established.26 Animal studies have shown that mild head injury causes such oxidative stress injury and subtle axonal damage in the absence of gross focal lesions, contusions, or laceration.7,8 This is in relation with the biomolecular response to trauma: the release of excitatory amino acids is associated with calcium influx into neurons that consequently determines oxygen radical reaction27; additional sources of free radicals include the arachidonic acid cascade, mitochondria leakage, xanthine oxidase activity, and the autoxidation of amine neurotransmitters.28 When free radicals accumulate and the pH is lowered, the conditions are favorable for the deposition of iron, which subsequently keeps the inflammatory response triggered. It also has been shown that trauma-induced increased blood-brain barrier permeability9 and regional hemoglobin degradation products can be found in the absence of local lesions or distant to the site of primary insult,10 suggesting another mechanism for excessive iron deposition in TBI. In addition, a pathologic case report in a patient with mTBI who died unexpectedly showed a considerable amount of hemosiderin-laden macrophages in the frontal lobe, though both the CT and the gross macroscopic postmortem evaluation were negative.29 This is in line with findings in experimental models of brain trauma where diffuse brain hemosiderin deposits were present even when no gross detection of hemorrhage was identified,30 and with the demonstrated improvement in spatial memory performance in animal models of trauma after treatment with deferoxamine, an iron scavenger.31 Although any attempt to interpret the underlying substrate of MFC changes is speculative, and could only be confirmed by a postmortem examination, our findings of microstructural damage in basal ganglia and thalami in patients with mTBI are supported by studies using independent imaging techniques. We cannot rule out that the iron deposition in the thalamus and globus pallidus, suggested by our MFC measurements, is secondary to DAI, microhemorrhages, and microgliosis of the white matter tracts surrounding the deep gray matter structure. Similarly to what has been described in other neurologic diseases,32 it might be possible that due to the injury of axons that project to the cortex, the iron is still taken up by deep gray matter structures, but its centrifugal transportation to the cortex is impaired leading to local accumulation.

We did not find any correlations between the increase of MFC in the thalamus and in the globus pallidus and the PCSS, Stroop, and VFT test scores. Although Stroop and VFT can measure attention and processing speed and are widely used in the assessment of patients with TBI, they are mainly a measure of executive functions and hence were correlated with the MFC value of the frontal white matter. Future studies using a more comprehensive neuropsychological battery will help in understanding the clinical relevance of iron deposition in thalamus and basal ganglia.

We did not find increased MFC values in the examined white matter regions of patients with mTBI; this can be partly explained by the fact that we evaluated only the frontal white matter and the splenium of the corpus callosum. Whereas the deep gray matter is sensitive to shear and strain damage due to its central location in the brain, the white matter injury is more dependent on the site of head injury, which varied in our patients. However, because we focused on the splenium of the corpus callosum, which is a site of predilection for DAI, the absence of detectable MFC changes also might be related to limitation of the technique used. For example, our sequence only measured the MFC at a single time point (TE/2 = 20 ms) and would be insensitive to MFIs with a length scale small compared with the diffusion length (3D*TE) 1/2≈7.7/μm (assuming a water diffusion coefficient of D = 1/μm2/ms).

Finally, the cross-sectional design of our study limits our understanding of the timing and role of iron accumulation. Ongoing longitudinal studies in patients with acute mTBI will provide a better understanding of the pathophysiologic cascade of events leading to brain iron accumulation. The application of MFC MR imaging in neurologic diseases associated with well-known changes in tissue iron deposition12,13,15 supports its potential to provide insights into the pathophysiologic mechanisms of tissue injury in mTBI.

Conclusions

To the best of our knowledge, this is the first study investigating the presence of tissue iron deposition in patients with mTBI. Using a recently developed MR imaging technique, sensitive to the presence of iron deposits, we found significantly increased MFC values in the thalamus and globus pallidus of patients with mTBI, probably reflecting iron accumulation. Our findings corroborate the evidence of deep gray matter as a frequent site of injury in mTBI, and support the hypothesis of a possible role for iron accumulation in the pathophysiologic events after mTBI.

Acknowledgments

We thank Drs Ali Tabesh and Cathy Hu for helpful technical assistance.

Footnotes

  • This study was supported by the National Institute of Health grants R01 NS039135 and R01 NS051323.

  • Disclosures: Robert I. Grossman, Research Support (including provision of equipment or materials): National Institutes of Health grant R01 NS039135.

Indicates open access to non-subscribers at www.ajnr.org

References

  1. 1.↵
    1. Brown AW,
    2. Leibson CL,
    3. Malec JF,
    4. et al
    . Long-term survival after traumatic brain injury: a population-based analysis. Neurorehabilitation 2004;19:37–43
    PubMed
  2. 2.↵
    1. Bazarian JJ,
    2. McClung J,
    3. Shah MN,
    4. et al
    . Mild traumatic brain injury in the United States, 1998–2000. Brain Injury 2005;19:85–91
    PubMed
  3. 3.↵
    1. Ropper AH,
    2. Gorson KC
    . Clinical practice. Concussion. N Engl J Med 2007;356:166–72
    CrossRef
  4. 4.↵
    1. Thurman DJ,
    2. Alverson C,
    3. Dunn KA,
    4. et al
    . Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 1999;14:602–15
    PubMed
  5. 5.↵
    1. Hammoud DA,
    2. Wasserman BA
    . Diffuse axonal injuries: pathophysiology and imaging. Neuroimaging Clin N Am 2002;12:205–16
    CrossRefPubMed
  6. 6.↵
    1. Medana IM,
    2. Esiri MM
    . Axonal damage: a key predictor of outcome in human CNS diseases. Brain 2003;126:515–30
    Abstract/FREE Full Text
  7. 7.↵
    1. Bakay L,
    2. Lee JC,
    3. Lee GC,
    4. et al
    . Experimental cerebral concussion. Part 1: an electron microscopic study. J Neurosurg 1977;47:525–31
    PubMed
  8. 8.↵
    1. Jane JA,
    2. Steward O,
    3. Gennarelli TA
    . Axonal degeneration induced by experimental noninvasive minor head injury. J Neurosurg 1985;62:96–100
    PubMed
  9. 9.↵
    1. Adelson PD,
    2. Whalen MJ,
    3. Kochanek PM,
    4. et al
    . Blood brain barrier permeability and acute inflammation in two models of traumatic brain injury in the immature rat: a preliminary report. Acta Neurochir Suppl 1998;71:104–06
    PubMed
  10. 10.↵
    1. Povlishock JT
    . Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol 1992;2:1–12
    PubMed
  11. 11.↵
    1. Onyszchuk G,
    2. Levine SM,
    3. Brooks WM,
    4. et al
    . Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci Lett 2009;452:204–08
    CrossRefPubMed
  12. 12.↵
    1. Jensen JH,
    2. Szulc K,
    3. Hu C,
    4. et al
    . Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009;61:481–85
    CrossRefPubMed
  13. 13.↵
    1. Jensen JH,
    2. Chandra R,
    3. Ramani A,
    4. et al
    . Magnetic field correlation imaging. Magn Reson Med 2006;55:1350–61
    CrossRefPubMed
  14. 14.↵
    1. Sukstanskii AL,
    2. Yablonskiy DA
    . Gaussian approximation in the theory of MR signal formation in the presence of structure-specific magnetic field inhomogeneities. J Magn Reson 2003;163:236–47
    CrossRefPubMed
  15. 15.↵
    1. Ge Y,
    2. Jensen JH,
    3. Lu H,
    4. et al
    . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR J Neuroradiol 2007;28:1639–44
    CrossRef
  16. 16.↵
    1. Kay T,
    2. Harrington D,
    3. Adams R,
    4. et al
    . Definition of mild traumatic brain injury. J Head Trauma Rehabil 1993;8:86–87
    CrossRef
  17. 17.↵
    1. Trenerry M,
    2. Crosson B,
    3. LeBoe J,
    4. et al
    . Stroop Neuropsychological Screening Test Manual. Odessa, Florida: Psychological Assessment Resources; 1989
  18. 18.↵
    1. Delis DC,
    2. Kramer JH,
    3. Kaplan E,
    4. et al
    . Reliability and validity of the Delis-Kaplan Executive Function System: an update. J Int Neuropsychol Soc 2004;10:301–03
    PubMed
  19. 19.↵
    1. Aubry M,
    2. Cantu R,
    3. Dvorak J,
    4. et al
    . Summary and agreement statement of the First International Conference on Concussion in Sport, Vienna 2001. Recommendations for the improvement of safety and health of athletes who may suffer concussive injuries. Br J Sports Med 2002;36:6–10
  20. 20.↵
    1. Lull N,
    2. Noé E,
    3. Lull JJ,
    4. et al
    . Thalamic metabolism and neurological outcome after traumatic brain injury. A voxel-based morphometric FDG-PET study. Neurologia 2010;25:174–80
    PubMed
  21. 21.↵
    1. Lifshitz J,
    2. Kelley BJ,
    3. Povlishock JT
    . Perisomatic thalamic axotomy after diffuse traumatic brain injury is associated with atrophy rather than cell death. J Neuropathol Exp Neurol 2007;66:218–29
    CrossRefPubMed
  22. 22.↵
    1. Haber SN,
    2. Calzavara R
    . The cortico-basal ganglia integrative network: the role of the thalamus. Brain Res Bull 2009;78:69–74
    CrossRefPubMed
  23. 23.↵
    1. Shaw NA
    . The neurophysiology of concussion. Prog Neurobiol 2002;67:281–344
    CrossRefPubMed
  24. 24.↵
    1. Sipe JC,
    2. Lee P,
    3. Beutler E
    . Brain iron metabolism and neurodegenerative disorders. Dev Neurosci 2002;24:188–96
    CrossRefPubMed
  25. 25.↵
    1. Connor JR,
    2. Menzies SL,
    3. Burdo JR,
    4. et al
    . Iron and iron management proteins in neurobiology. Pediatr Neurol 2001;25:118–29
    CrossRefPubMed
  26. 26.↵
    1. Campbell A,
    2. Smith MA,
    3. Sayre LM,
    4. et al
    . Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 2001;55:125–32
    CrossRefPubMed
  27. 27.↵
    1. Greve MW,
    2. Zink BJ
    . Pathophysiology of traumatic brain injury. Mt Sinai J Med 2009;76:97–104
    CrossRefPubMed
  28. 28.↵
    1. Hall ED,
    2. Vaishnav RA,
    3. Mustafa AG
    . Antioxidant therapies for traumatic brain injury. Neurotherapeutics 2010;7:51–61
    CrossRefPubMed
  29. 29.↵
    1. Bigler ED
    . Neuropsychological results and neuropathological findings at autopsy in a case of mild traumatic brain injury. J Int Neuropsychol Soc 2004;10:794–806
    PubMed
  30. 30.↵
    1. Adelson PD,
    2. Jenkins LW,
    3. Hamilton RL,
    4. et al
    . Histopathologic response of the immature rat to diffuse traumatic brain injury. J Neurotrauma 2001;18:967–76
    CrossRefPubMed
  31. 31.↵
    1. Long DA,
    2. Ghosh K,
    3. Moore AN,
    4. et al
    . Deferoxamine improves spatial memory performance following experimental brain injury in rats. Brain Res 1996;717:109–17
    CrossRefPubMed
  32. 32.↵
    1. Craelius W,
    2. Migdal MW,
    3. Luessenhop CP,
    4. et al
    . Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397–99
    PubMed
  • Received January 10, 2011.
  • Accepted after revision February 26, 2011.
View Abstract
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Citation Tools
Brain Iron Quantification in Mild Traumatic Brain Injury: A Magnetic Field Correlation Study
E. Raz, J.H. Jensen, Y. Ge, J.S. Babb, L. Miles, J. Reaume, R.I. Grossman, M. Inglese
American Journal of Neuroradiology Nov 2011, 32 (10) 1851-1856; DOI: 10.3174/ajnr.A2637
del.icio.us logo Twitter logo Facebook logo Mendeley logo
Purchase

Jump to section

Related Articles

  • No related articles found.

Cited By...

More in this TOC Section

Similar Articles

Advertisement